Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Jeffrey Tabas Added: 3 years ago
Approximately five million people present to the emergency department (ED) each year with chest pain, and billions of dollars are spent on assessment and treatment. Many therapies are time-dependent, so rapid identification of patients with acute coronary syndrome (ACS) - unstable angina (UA) and acute myocardial infarction (MI) - at high risk for adverse outcomes is essential. Missed or… View more

Prevention & Chronic Conditions

MI/ACS
ACC 2018: Alirocumab in patients after acute coronary syndrome
Author(s): Deepak L Bhatt Added: 6 years ago
Deepak Bhatt discusses the ODYSSEY Outcomes trial - alirocumab in patients after acute coronary syndrome. Filmed by Radcliffe Cardiology on-site at the American College of Cardiology congress 2018 in Orlando, USA View more

MI/ACS
ACC 22: Results from the GIPS-IV Trial
Author(s): Pim van der Harst , Added: 2 years ago
In this short interview from our coverage of the ACC.22 late-breaking trials, Dr Pim van der Harst and Dr Marie-Sophie de Koning (University Medical Center Groningen, NL) discuss the data from the GIPS-IV trial which investigates the safety and efficacy of the hydrogen sulfide (H2S) donor sodium thiosulfate (STS) in patients presenting with ST-segment elevation myocardial infarction (STEMI) … View more

MI/ACS
Stefan James
Job title: Professor of Cardiology
Prof Stefan James is Professor of Cardiology at Uppsala University, Scientific Director of Uppsala Clinical Research Center and a senior Interventional Cardiologist at Uppsala University Hospital in Sweden. He is the president of the Swedish society of Cardiology and a Fellow of the ESC.He graduated from Uppsala University Medical School and completed specialist training in Uppsala. He has… View more
Thumbnail
Author(s): Kiyuk Chang Added: 2 years ago
In this video, Dr Kiyuk Chang (Seoul St. Mary's Hospital, Seoul, South Korea) discusses the results of the TALOS AMI Trial, a multicenter study evaluating the effects of Clopidogrel versus Ticagrelor in stabilised patients after acute myocardial infarction. Questions: 1. What is the rationale of the TALOS AMI trial? 2. What was study design, patient population and endpoints? 3. What are the key… View more

MI/ACS
TCT 2018: CorMicA
Author(s): Tom Ford Added: 5 years ago
Dr Tom Ford (University of Glasgow, Glasgow, UK) discusses CorMicA - A randomised trial of invasive coronary function testing in patients with angina and nonobstructive coronary artery disease. Filmed by Radcliffe Cardiology on site TCT 2018. View more

MI/ACS
Role of Intracoronary Imaging in Acute Coronary Syndromes
Author(s): Gregory Petrossian , Denizhan Ozdemir , Keyvan Karimi Galougahi , et al Added: 1 year ago

Imaging & Diagnostics

MI/ACS
Author(s): Sandeep Nathan , Rajiv Swamy Added: 3 years ago
The spectrum of acute coronary syndromes (ACS) encompasses a broad array of clinical characteristics and risk strata, ranging from unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI) to ST-segment elevation myocardial infarction (STEMI) and sudden cardiac death (SCD). In this article, UA and NSTEMI will be considered together as non-ST-segment elevation acute coronary… View more

Anticoagulation
ESC 23: The STOPDAPT-3 Study
Author(s): Masahiro Natsuaki Added: 7 months ago
ESC 23 — Dr Masahiro Natsuaki (Saga University, JP) discusses the short and optimal duration of dual antiplatelet therapy-3 Study (STOPDAPT-3) (NCT04609111). In the STOPDAPT-2 study, 1-month dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy was shown to provide benefits in bleeding reduction over a 12-month period, however, other trials have shown high rates of bleeding at… View more

MI/ACS

Intervention
CRT 2019: ALERTS Trial
Author(s): Michael C Gibson Added: 5 years ago
Dr C Michael M Gibson (Beth Israel Deaconess Medical Center, Boston, MA, US) discusses the Angelmed for early recognition and treatment of STEMI (ALERTS) trail. Filmed on site at CRT 2019 by Radcliffe Cardiology Questions: 1. What is the rationale for this study? 2. What was the design, number of patients enrolled and study endpoints? 3. What should this mean for clinical practice and… View more

MI/ACS